Prior to joining Pivotal Life Sciences Lisa was a senior research analyst at NF Trinity, Nan Fung Group’s financial investment arm, where she was responsible for the fund’s publicly listed investments in the global healthcare sector. Prior to NF Trinity, Lisa was a senior analyst at Agamemnon Capital, a global event–driven hedge fund, where she focused on the healthcare sector. She was also an Assistant Vice President at SAFE, the Chinese sovereign wealth fund, managing its global healthcare holdings. She started her career in private equity with Morgan Stanley in San Francisco. Lisa earned her MBA from The Wharton School at University of Pennsylvania, and her Bachelor of Science and Bachelor of Arts degrees from University of California, Berkeley.
Director – Pivotal Life Sciences & Public Investing